Strategies to Maintain Tight Control of Rheumatoid Arthritis
Release date: April 2009
Expiration date: April 30, 2010
No longer available for credit
Estimated time to complete activity: 30 minutes
Sponsored by Curatio CME Institute
Support for this activity has been provided through educational grants from Genentech, Inc., Biogen Idec, Amgen, Wyeth, and UCB.
Activity Overview
Intensive management, or tight control, of rheumatoid arthritis (RA) has been shown to be associated with better patient outcomes. For this issue of Expert Practice, we interviewed Philip Mease, MD, Chief of Rheumatology Research at the Swedish Medical Center and Clinical Professor of Medicine at the University of Washington in Seattle, Washington. He provided insights regarding the benefits of maintaining tight control in the treatment of RA as well as tips on how to quantify disease activity.
Target Audience
This activity has been designed to meet the educational needs of rheumatologists and other health care professionals involved in the care of patients with RA.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the concept of tight control of RA
- Define indicators of early progressive RA
- Apply best practices to achieve optimal control of RA
Faculty
Philip J. Mease, MD
Chief of Rheumatology Research
Swedish Medical Center
Clinical Professor of Medicine
University of Washington
Seattle, Washington
Accreditation Statement
Curatio CME Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
Curatio CME Institute designates this educational activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Method of Participation
There are no fees for participating in this CME activity. To receive credit during the period April 2009 to April 30, 2010, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, (3) complete the posttest, and (4) complete the activity evaluation form.
Media
The Internet was selected as the instructional format to accommodate the learning preferences of a significant portion of the target audience.
Disclosure
In accordance with the ACCME Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of everyone in a position to control content of an educational activity. A relevant financial relationship is a relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below:
Philip J. Mease, MD, has disclosed the following relevant financial relationships:
| Consultant | Abbott, Amgen, Biogen Idec, BMS, Centocor, Genentech, Roche, Sanofi-Aventis, UCB, Wyeth |
| Investigator | Abbott, Amgen, Biogen Idec, BMS, Centocor, Genentech, Roche, Wyeth |
| Speaker | Abbott, Amgen, Biogen Idec, BMS, Centocor, Genentech, Wyeth |
Curatio CME Institute
Shari J. Dermer, PhD, Medical Director, has disclosed no relevant financial relationships.
Adam J. Perahia, MD, Writer, has disclosed no relevant financial relationships.
Barbara Bekiesz, Editor, has disclosed no relevant financial relationships.
Derek Warnick, CME Director, has disclosed no relevant financial relationships.
Disclaimer
The information presented in this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.
Unapproved Product Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Curatio CME Institute, Genentech, Inc., Biogen Idec, Amgen and Wyeth, and UCB do not recommend the use of any agent outside the labeled indications.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Curatio CME Institute, Genentech, Inc., Biogen Idec, Amgen and Wyeth, or UCB. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Hardware/Software Requirements
- JavaScript-enabled Interner browswer
Contact Information
RAoutlook.org
100 Campbell Boulevard
Suite 103
Exton, PA 19341
raoutlook@curatiocme.com
Policy on Privacy and Confidentiality
Curatio CME Institute makes every effort to protect the privacy of RAoutlook.org users; user information is used only to maintain records as required by the American Medical Association (AMA) and the Accreditation Council for Continuing Medical Education (ACCME).
Curatio CME Institute does not require individuals to register to use RAoutlook.org; registration is only required for physicians, health care professionals, and other users to participate in and receive CME/CE credit for accredited educational programs hosted on RAoutlook.org.
Curatio CME Institute is required by the AMA and the ACCME (and occasionally by other accrediting organizations) to collect user information that will allow Curatio CME Institute to issue a CME/CE certificate. Curatio CME Institute is required to keep this information on file for up to 6 years. The information is stored in a secure database and used only to verify individual participation in a CME/CE activity and to reissue a certificate if a user’s original certificate is lost or misplaced.
Information gathered through RAoutlook.org will not be released to any other company or organization for any purpose; this information remains confidential. At the end of the mandatory 6-year period, these records will be permanently destroyed.
Curatio CME Institute uses Web site tracking software to determine how RAoutlook.org is used. This information helps Curatio CME Institute determine the best strategies for improving RAoutlook.org and better meeting the needs of its users. This software does not identify individual users.
If you have any questions about RAoutlook.org or any policies of Curatio CME Institute, you may contact us at raoutlook@curatiocme.com.
Thank you for using RAoutlook.org.
